journal article·2024-09Open access

Dissecting the Impact of Maternal Androgen Exposure on Developmental Programming through Targeting the Androgen Receptor

Haojiang Lu, Hong Jiang, Congru Li, Emilie Derisoud, Allan Zhao, Gustaw Eriksson, Eva Lindgren, Han‐Pin Pui, Sanjiv Risal, Yu Pei, Theresa Maxian, Claes Ohlsson, Anna Benrick, Sandra Haider, Elisabet Stener‐Victorin, Qiaolin Deng

Advanced Science· Volume 11· Issue 36

Abstract

Abstract Women with polycystic ovary syndrome (PCOS) exhibit sustained elevation in circulating androgens during pregnancy, an independent risk factor linked to pregnancy complications and adverse outcomes in offspring. Yet, further studies are required to understand the effects of elevated androgens on cell type‐specific placental dysfunction and fetal development. Therefore, a PCOS‐like mouse model induced by continuous androgen exposure is examined. The PCOS‐mice exhibited impaired placental and embryonic development, resulting in mid‐gestation lethality. Co‐treatment with the androgen receptor blocker, flutamide, prevents these phenotypes including germ cell specification. Comprehensive profiling of the placenta by whole‐genome bisulfite and RNA sequencing shows a reduced proportion of trophoblast precursors, possibly due to the downregulation of Cdx2 expression. Reduced expression of Gcm1 , Synb , and Prl3b1 is associated with reduced syncytiotrophoblasts and sinusoidal trophoblast giant cells, impairs placental labyrinth formation. Importantly, human trophoblast organoids exposed to androgens exhibit analogous changes, showing impaired trophoblast differentiation as a key feature in PCOS‐related pregnancy complications. These findings provide new insights into the potential cellular targets for future treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Birth, Development, and Health · Reproductive Biology and Fertility · Sexual Differentiation and Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology and Pharmacology Karolinska Institutet Stockholm 17177 Sweden

Department of Obstetrics and Gynaecology Reproductive Biology Unit, Placental Development Group Medical University of Vienna Vienna 1090 Austria

Centre for Bone and Arthritis Research Department of Internal Medicine and Clinical Nutrition Institute of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg 40530 Sweden

Department of Physiology Sahlgrenska Academy University of Gothenburg Gothenburg 40530 Sweden

School of Health Sciences University of Skövde Skövde 54128 Sweden

Funding

Medicinska Forskningsrådet · Knut och Alice Wallenbergs Stiftelse · Novo Nordisk Fonden · Stockholms Läns Landsting

References (82)

Show source-provided references
1. 10.1093/humupd/dmw02510.1093/humupd/dmw025 ↗
2. 10.1016/j.fertnstert.2016.05.00310.1016/j.fertnstert.2016.05.003 ↗
3. 10.1111/obr.1282910.1111/obr.12829 ↗
4. 10.1016/j.fertnstert.2009.10.04310.1016/j.fertnstert.2009.10.043 ↗
5. 10.1016/j.xcrm.2023.10103510.1016/j.xcrm.2023.101035 ↗
6. 10.1038/s41591-019-0666-110.1038/s41591-019-0666-1 ↗
7. 10.1038/s41576-019-0169-410.1038/s41576-019-0169-4 ↗
8. 10.1093/biolre/ioy04910.1093/biolre/ioy049 ↗
9. 10.1016/j.placenta.2020.05.00310.1016/j.placenta.2020.05.003 ↗
10. 10.1038/nbt128010.1038/nbt1280 ↗
11. 10.1074/jbc.C60001520010.1074/jbc.C600015200 ↗
12. 10.1093/humrep/dead05010.1093/humrep/dead050 ↗
13. 10.1093/humrep/17.10.257310.1093/humrep/17.10.2573 ↗
14. 10.1016/j.ejogrb.2012.10.01510.1016/j.ejogrb.2012.10.015 ↗
15. 10.1016/j.rbmo.2014.04.01010.1016/j.rbmo.2014.04.010 ↗
16. 10.1093/humrep/det25010.1093/humrep/det250 ↗
17. Gong H. · PLoS One · 2019 · 14
18. 10.1007/s00109-021-02104-z10.1007/s00109-021-02104-z ↗
19. 10.1038/s41398-020-01183-910.1038/s41398-020-01183-9 ↗
20. 10.1210/jc.2007-103610.1210/jc.2007-1036 ↗
21. 10.1080/09513590.2022.212138610.1080/09513590.2022.2121386 ↗
22. 10.1210/jc.2017-0266710.1210/jc.2017-02667 ↗
23. 10.1017/S204017441700111810.1017/S2040174417001118 ↗
24. 10.1530/EC-17-021810.1530/EC-17-0218 ↗
25. 10.1210/jc.2007-225610.1210/jc.2007-2256 ↗
26. 10.1210/en.2016-155310.1210/en.2016-1553 ↗
27. 10.7554/eLife.8645410.7554/eLife.86454 ↗
28. 10.1093/humrep/dev19510.1093/humrep/dev195 ↗
29. 10.3181/0710-MR-28710.3181/0710-MR-287 ↗
30. 10.1042/bj357003310.1042/bj3570033 ↗
31. 10.1042/bj338056910.1042/bj3380569 ↗
32. 10.1093/jmcb/mjy05410.1093/jmcb/mjy054 ↗
33. 10.1038/4202210.1038/42022 ↗
34. 10.1002/wsbm.4410.1002/wsbm.44 ↗
35. 10.1017/S003329171900042410.1017/S0033291719000424 ↗
36. 10.1038/nrendo.2018.2410.1038/nrendo.2018.24 ↗
37. 10.1038/s41574-021-00517-x10.1038/s41574-021-00517-x ↗
38. 10.3390/biom1106082210.3390/biom11060822 ↗
39. 10.1007/s00125-022-05746-x10.1007/s00125-022-05746-x ↗
40. 10.1038/s41421-022-00513-z10.1038/s41421-022-00513-z ↗
41. 10.1007/BF0004952510.1007/BF00049525 ↗
42. 10.1073/pnas.111230410810.1073/pnas.1112304108 ↗
43. 10.1038/7707610.1038/77076 ↗
44. 10.1016/j.ydbio.2005.05.01010.1016/j.ydbio.2005.05.010 ↗
45. 10.1161/HYPERTENSIONAHA.111.18393910.1161/HYPERTENSIONAHA.111.183939 ↗
46. 10.1073/pnas.090292510610.1073/pnas.0902925106 ↗
47. 10.12717/DR.2018.22.3.26310.12717/DR.2018.22.3.263 ↗
48. 10.1038/ng.47110.1038/ng.471 ↗
49. 10.1038/nn.358810.1038/nn.3588 ↗
50. 10.1038/cr.2015.10010.1038/cr.2015.100 ↗
51. 10.1016/j.stemcr.2018.07.00410.1016/j.stemcr.2018.07.004 ↗
52. 10.1016/j.placenta.2013.06.30510.1016/j.placenta.2013.06.305 ↗
53. 10.1210/endrev/bnaa01010.1210/endrev/bnaa010 ↗
54. 10.7554/eLife.6026610.7554/eLife.60266 ↗
55. 10.1016/j.ebiom.2020.10299310.1016/j.ebiom.2020.102993 ↗
56. 10.1038/4202210.1038/42022 ↗
57. 10.1038/sj.emboj.760053810.1038/sj.emboj.7600538 ↗
58. 10.1387/ijdb.082768dh10.1387/ijdb.082768dh ↗
59. 10.1016/j.placenta.2015.05.01310.1016/j.placenta.2015.05.013 ↗
60. 10.1093/molehr/gaz03810.1093/molehr/gaz038 ↗
61. 10.1073/pnas.220307111910.1073/pnas.2203071119 ↗
62. 10.1016/j.placenta.2021.05.00210.1016/j.placenta.2021.05.002 ↗
63. 10.1155/2015/45173510.1155/2015/451735 ↗
64. 10.1016/j.placenta.2009.10.00410.1016/j.placenta.2009.10.004 ↗
65. 10.3390/ijms2305278510.3390/ijms23052785 ↗
66. 10.1210/jc.2004-226510.1210/jc.2004-2265 ↗
67. 10.1093/toxsci/kfi15910.1093/toxsci/kfi159 ↗
68. 10.1210/clinem/dgad46310.1210/clinem/dgad463 ↗
69. Giorgetti R. · Eur. Rev. Med. Pharmacol. Sci. · 2017 · 21 · 69
70. 10.1038/s42003-022-04362-010.1038/s42003-022-04362-0 ↗
71. Xue P. · Jove‐J. Vis. Exp. · 2018 · 140
72. 10.1210/clinem/dgab86710.1210/clinem/dgab867 ↗
73. 10.1038/nprot.2013.09010.1038/nprot.2013.090 ↗
74. 10.1242/dev.06558110.1242/dev.065581 ↗
75. 10.1038/s41587-020-0497-010.1038/s41587-020-0497-0 ↗
76. 10.1093/gigascience/giy05910.1093/gigascience/giy059 ↗
77. 10.1093/bioinformatics/bts63510.1093/bioinformatics/bts635 ↗
78. 10.1186/s13059-022-02660-810.1186/s13059-022-02660-8 ↗
79. 10.1186/s13059-014-0550-810.1186/s13059-014-0550-8 ↗
80. 10.1038/s41587-019-0114-210.1038/s41587-019-0114-2 ↗
81. 10.1093/bioinformatics/btu33910.1093/bioinformatics/btu339 ↗
82. 10.1096/fj.201701263RR10.1096/fj.201701263RR ↗